Michael Wang

HTC Clinical Director; Professor of Pediatrics Hematology/Oncology
University of Colorado School of Medicine
Aurora, Colorado, United States

Presentation(s):

• PB0205 - Long-term safety and effectiveness of emicizumab in people with hemophilia A in the Hemophilia Natural History Study (ATHN 7)

  Sunday, June 23, 2024
  13:45 – 14:45 ICT